The Valley Desk

NCT06211764 · Interventional trial

A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG)

Overall registry status Active not recruiting

Phase 3

Conditions Non-Muscle Invasive Bladder Neoplasms

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov